HOME
Vol , Issue
Date of Publication: January 01, 2004
DOI: https://doi.org/10.20529/IJME.2004.008
Views
, PDF Downloads:
Discussions
Unhealthy drug donations
Abstract:
In mid-2002, the German multinational Boehringer Ingelheim got much publicity following its announcement that it would donate the drug nevirapine to developing countries for programmes preventing maternal–foetal transmission of HIV. Company spokespeople stated that this donation was a response to the AIDS crisis in South Africa.
Copyright and license ©Indian Journal of Medical Ethics 2016: Open Access and Distributed under the Creative Commons license ( CC BY-NC-ND 4.0), which permits only non-commercial and non-modified sharing in any medium, provided the original author(s) and source are credited.
